Revenue · 2011–2025

Adma Biologics revenue

$510M+19.6% · FY2025

Adma Biologics (ADMA) reported $510M in revenue for fiscal 2025, +19.6% year on year.

$761,0422011$1.1M2012$3.1M2013$5.9M2014$7.2M2015$10.7M2016$22.8M2017$17.0M2018$29.3M2019$42.2M2020$80.9M2021$154M2022$258M2023$426M2024$510M2025
Adma Biologics — Revenue, 2011–2025
Fiscal yearRevenueChangeFiling
FY20252025-12-31$510M+19.6%Open →
FY20242024-12-31$426M+65.2%Open →
FY20232023-12-31$258M+67.6%Open →
FY20222022-12-31$154M+90.4%Open →
FY20212021-12-31$80.9M+91.7%Open →
FY20202020-12-31$42.2M+43.9%Open →
FY20192019-12-31$29.3M+72.8%Open →
FY20182018-12-31$17.0M−25.4%Open →
FY20172017-12-31$22.8M+113.5%Open →
FY20162016-12-31$10.7M+48.5%Open →
FY20152015-12-31$7.2M+21.3%Open →
FY20142014-12-31$5.9M+92.8%Open →
FY20132013-12-31$3.1M+174.4%Open →
FY20122012-12-31$1.1M+46.9%Open →
FY20112011-12-31$761,042—Open →

Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +59.2%

Revenue at companies of similar size

Full ranking by revenue →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Adma Biologics revenue |url=https://companiesranked.com/en/company/adma-biologics/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Adma Biologics revenue. CompaniesRanked. https://companiesranked.com/en/company/adma-biologics/revenue

BibTeX

@misc{companiesranked-en-company-adma-biologics-revenue-2026,
  author       = {{CompaniesRanked}},
  title        = {{Adma Biologics revenue}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/adma-biologics/revenue}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001140361-26-006815 · February 25, 2026

{{cite web |title=Adma Biologics revenue — 10-K (0001140361-26-006815) |url=https://www.sec.gov/Archives/edgar/data/1368514/000114036126006815/ef20059416_10-k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Adma Biologics overview